Strawberry downy mildew

Taxonomy and Pathogen Type: The causal agent of this disease is the oomycete Peronospora fragariae. Belonging to the Kingdom Chromista, this organism is an obligate biotroph, meaning it requires living host tissue to complete its life cycle and derive nutrients. It is specifically adapted to parasitize strawberry plants.

Diseases and Host Crops: Peronospora fragariae is responsible for downy mildew in strawberries. The disease primarily affects the foliage, where it causes chlorotic, angular spots on the upper leaf surface. Under high humidity conditions, a diagnostic grayish-purple downy growth appears on the undersides of the leaves, representing the pathogen's sporangiophores and sporangia.

Biology and Life Cycle: The pathogen survives the winter as oospores in infected plant debris or in the crowns of perennial strawberry plants. In the spring, these oospores germinate in the presence of free water to initiate primary infections. The disease then spreads rapidly through the production of asexual sporangia, which are disseminated by wind, rain splashes, and irrigation water, leading to secondary infection cycles.

Conditions for Development: The proliferation of downy mildew is heavily dependent on environmental factors. Cool to moderate temperatures, typically between +15°C and +22°C, combined with high relative humidity or prolonged leaf wetness, create ideal conditions for infection. Poor airflow in planting beds or greenhouses significantly exacerbates the rapid spread of the pathogen.

Damage and Management: The economic impact of strawberry downy mildew includes severe defoliation, reduced photosynthesis, and weakened plants, which directly lead to lower yields and inferior fruit quality. Effective control strategies include:

• Planting certified disease-free nursery stock.
• Ensuring adequate plant spacing to promote leaf drying and air circulation.
• Sanitation, including the removal and destruction of infected foliage.
• Applying preventive or curative fungicide sprays, such as systemic metalaxyl or contact copper-based treatments, when favorable conditions for the disease occur.